American Journal of Ophthalmology
Volume 149, Issue 5 , Page 867 , May 2010

Randomized Study of Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Inappropriate Conclusions

Reference 

  1. Subramanian ML, Ness S, Abedi G, et al. Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial. Am J Ophthalmol. 2009;148(6):875–882

PII: S0002-9394(10)00015-2

doi: 10.1016/j.ajo.2009.12.039

American Journal of Ophthalmology
Volume 149, Issue 5 , Page 867 , May 2010